Pacific Biosciences of California Inc
NASDAQ:PACB
Pacific Biosciences of California Inc
Net Income (Common)
Pacific Biosciences of California Inc
Net Income (Common) Peer Comparison
Competitive Net Income (Common) Analysis
Latest Figures & CAGR of Competitors
Company | Net Income (Common) | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Pacific Biosciences of California Inc
NASDAQ:PACB
|
Net Income (Common)
-$306.7m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
-24%
|
CAGR 10-Years
-14%
|
|
Thermo Fisher Scientific Inc
NYSE:TMO
|
Net Income (Common)
$6B
|
CAGR 3-Years
-2%
|
CAGR 5-Years
15%
|
CAGR 10-Years
17%
|
|
Danaher Corp
NYSE:DHR
|
Net Income (Common)
$8.1B
|
CAGR 3-Years
21%
|
CAGR 5-Years
27%
|
CAGR 10-Years
12%
|
|
Mettler-Toledo International Inc
NYSE:MTD
|
Net Income (Common)
$788.8m
|
CAGR 3-Years
9%
|
CAGR 5-Years
9%
|
CAGR 10-Years
10%
|
|
Agilent Technologies Inc
NYSE:A
|
Net Income (Common)
$1.2B
|
CAGR 3-Years
15%
|
CAGR 5-Years
2%
|
CAGR 10-Years
5%
|
|
IQVIA Holdings Inc
NYSE:IQV
|
Net Income (Common)
$1.4B
|
CAGR 3-Years
69%
|
CAGR 5-Years
39%
|
CAGR 10-Years
20%
|
See Also
What is Pacific Biosciences of California Inc's Net Income (Common)?
Net Income (Common)
-306.7m
USD
Based on the financial report for Dec 31, 2023, Pacific Biosciences of California Inc's Net Income (Common) amounts to -306.7m USD.
What is Pacific Biosciences of California Inc's Net Income (Common) growth rate?
Net Income (Common) CAGR 10Y
-14%
Over the last year, the Net Income (Common) growth was 2%.